Ringside

Post-BellWednesday, August 19, 2026

Indexes

The Treasury Department, not the Federal Reserve, set the terms of this session. Early Wednesday it said it would at least double the size of its liquidity-support buyback operations in the 10-to-30-year sector, lifting the cap from $2 billion an operation to $4 billion starting September 9 and running through November 4. Yields at the far end dropped on the news, with the thirty-year off about eight basis points to 5.21% a day after touching its highest level since 2007, and the dollar index slid 0.85% to 98.80, its weakest since late May. Anything priced off a softer dollar and a lower curve worked: gold gained 3.66%, the Russell 2000 added 0.50%, and health care led all eleven sectors by a wide margin. Then the July Fed minutes arrived at 2:00 p.m. Eastern showing a 9-3 vote to hold, three regional presidents preferring a quarter-point increase, and the S&P 500 surrendered most of a 0.6% midday gain to finish at 7,707.98. It kept enough of it that the session low of 7,700.07 still sat above Tuesday's close, so the index never traded in the red.

Daily bars for the S&P 500 ETF, which closed at $769.06.

Sector Heat Map

One drug trial reordered the entire board.

Eight of eleven sectors finished higher, and the three that did not were technology, industrials and financials. Money left the crowded artificial-intelligence hardware complex for almost everywhere else rather than for the defensive corner.

In the News

Rates, FX, Commodities

Wednesday's announcement worked on the far end of the curve and left the front alone, which flattened things from an unusual direction: two-year notes went nowhere while thirty-year paper rallied.

Precious metals took the currency move harder than currencies did. Silver rose 4.8% to $66.38, a two-month high alongside bullion, per Trading Economics.

A note on the two crude figures and the gold print: those are late-session quotes taken from Trading Economics shortly before publication, not exchange settlements, because Wednesday's official settlements had not been posted at the time of writing. Tuesday's settles, for reference, were $84.94 for West Texas Intermediate and $91.02 for Brent, per the Bloomberg wire carried by Rigzone.

Technicals

Closing at 7,707.98 leaves the broad benchmark 1.19% clear of its 20-day at 7,617.34 and 2.43% clear of the 50-day at 7,525.33, with the peak set on August 13 at 7,798.99, verified against the full daily series, now 1.18% overhead. The 100-name index is the weaker chart at 29,426.02, a quarter of a percent above its 50-day of 29,353.35. On rates, the ten-year at 4.65% has retraced roughly half of its August climb, while the two-year at 4.19% has not moved meaningfully since the month began.

Below is Moderna's hourly chart. Almost none of the gain came at the open: the stock spent the morning near $115, then ground higher for six straight hours to close at $174.38, at the top of a $114.46 to $176.66 range.

Hourly bars for Moderna, which closed Wednesday at $174.38.

Breakouts

Merck (MRK) closed at $152.20, a 16-month high per Trading Economics and 15.1% above its 50-day average of $126.74. It was the drugmaker's best session since March 2009, and the prior peak was cleared outright rather than tested. Target (TGT) at $159.00 also finished at a one-year high, 7.3% above its 20-day of $148.17, which is a strange place for a retailer that spent the spring in the low $80s.

Daily bars for Merck, closing at $152.20 after the melanoma readout.

Breakdowns

TJX Companies (TJX) lost all three of its moving averages in one session, closing at $144.50 against a 20-day of $156.04, a 50-day of $157.24 and a 200-day of $155.10. Nothing sits between here and the one-year low at $131.37. Chips added a second down session, with the VanEck Semiconductor ETF (SMH) at $560.92 under both its 20-day of $563.85 and its 50-day of $590.08, and Micron Technology (MU) at $937.10 still short of a 50-day average at $962.32 it has been chasing for four days.

Daily bars for TJX, closing at $144.50 beneath all three major averages.

Top Movers

Gainers

Moderna (MRNA) rose 176.97% to $174.38 after the Phase 3 INTerpath-001 trial of intismeran autogene plus Merck's Keytruda met its primary endpoint of recurrence-free survival and its secondary endpoint on distant metastasis in more than 1,100 patients with resected melanoma. Per the companies, it is the first positive late-stage readout for an mRNA cancer therapy and the first to beat Keytruda alone in the adjuvant setting. Short sellers lost about $5 billion on the move, Bloomberg reported, which explains some of the afternoon's persistence.

Merck (MRK) gained 12.60% to $152.20 as the other half of that partnership. The size of the reaction says the market had assigned the program almost no value inside a company of Merck's scale, and Keytruda's 2028 patent cliff is why a franchise extension gets paid for immediately.

Estée Lauder (EL) added 16.30% to $98.01 on fiscal fourth-quarter revenue of $3.6 billion, up 6% against a $3.54 billion consensus, with adjusted earnings of 39 cents a share, double the year-ago figure. The stock remains 18% below its February high of $119.61.

Target (TGT) rose 4.28% to $159.00 after second-quarter comparable sales grew 3.8% against a 2.5% consensus and management lifted its full-year net sales growth outlook to about 5%. Tariff refunds contributed $994 million of pretax profit in the quarter, or $1.65 a share after tax.

Losers

TJX Companies (TJX) fell 4.21% to $144.50 despite beating on every headline line: net sales of $15.2 billion up 5%, comparable sales up 4%, diluted earnings of $1.36 a share against $1.10 a year ago, and full-year adjusted guidance increased to $5.15 to $5.20. The trouble sat a level down, where HomeGoods, TJX Canada and TJX International each posted comparable sales growth of 6% to 7% while Marmaxx, by far the largest division, did not. A retailer at these multiples is expected to grow its core, not its edges.

Palo Alto Networks (PANW) lost 3.84% to $359.76, nine percent below its August 13 close of $396.00, on position-trimming ahead of its own fiscal fourth-quarter report rather than on any news.

SanDisk (SNDK) dropped 3.50% to $1,568.87, extending the memory unwind that began in Seoul overnight.

Key Macro Data Today

Three regional presidents wanted a hike in July while futures markets price roughly a one-in-three chance of one this year, and that gap has to close in one direction or the other.

Notable Earnings This Session

Retail dominated the calendar and a chipmaker stole it.

Pre-Open

Analog Devices delivered the quarter that mattered most to technology: fiscal third-quarter revenue of $4.02 billion, its first above $4 billion, with adjusted earnings of $3.45 a share against $3.34 expected. Fourth-quarter guidance of $4.2 billion to $4.4 billion in revenue and $3.71 to $4.01 in earnings sits above the $3.55 consensus. Lowe's finished up 2.02% at $220.00 after spending most of the session lower.

Post-Close

Nothing of consequence reported after the bell; Nvidia, the week's real event, is not scheduled until August 26.

Drivers

1. Walmart reports second-quarter results before the open, with the release at 6:00 a.m. Central and the call an hour later. The reports already in hand point in different directions: Target's comparable sales beat while TJX's core division lagged its smaller ones. The general merchandise line will say more than the headline.

2. The enlarged buyback operations do not begin until September 9, leaving nearly three weeks in which the far end of the curve holds its ground with no actual purchases behind it. The thirty-year at 5.21% sits twelve basis points below Tuesday's intraday high of 5.33%.

3. The chip complex sat out the entire move. SMH closed at $560.92, below both its 20-day and 50-day averages, and Micron at $937.10 has not reclaimed its own 50-day in four sessions. Nvidia reports on August 26.